Related Experiment Videos
Home nebuliser use in children with asthma in two Scottish Health Board Areas
P J Madge1, L Nisbet, J H McColl
1Department of Child Health, University of Glasgow, Yorkhill NHS Trust.
Insights
Home nebuliser therapy for childhood asthma is not meeting patient needs. The NHS supply and servicing are poorly organized, leading to suboptimal symptom control and potential overuse of medication.
Area of Science:
- Pediatric Respiratory Medicine
- Health Services Research
Background:
- Home nebuliser therapy is a common treatment for childhood asthma.
- Effective management requires adequate supply, technical support, and appropriate drug usage.
Purpose of the Study:
- To audit the utilization and support of home nebuliser devices for pediatric asthma patients.
- To assess the effectiveness of current home nebuliser services in managing asthma symptoms.
Main Methods:
- A postal questionnaire survey was conducted.
- The study included 297 children with asthma across two Health Board Areas in Central Scotland.
- Evaluated initial supply, technical support, drug usage patterns, and symptom control.
Main Results:
- National Health Service (NHS) provision for home nebuliser therapy is inadequate.
- Supply and servicing of nebuliser equipment were poorly organized.
- Chronic asthma symptoms were not optimally controlled, with 61% experiencing sleep disturbance; 20% of parents reported more frequent bronchodilator use than recommended.
Conclusions:
- Reorganization of resources and service arrangements is necessary.
- Improvements in service delivery can align home nebuliser therapy with recognized standards of care.
- Optimizing home nebuliser services can enhance symptom control for children with asthma.
Objective:
To audit the use of home nebulisers in children with asthma.
Design:
Postal questionnaire.
Setting:
Two Health Board Areas in Central Scotland--one large industrialised city, one mixed urban and rural.
Subjects:
297 children with asthma. MEASURES EVALUATED: Initial supply and technical support for the compressor.
Education:
Pattern of drug usage. SYMPTOM CONTROL: Monitoring and treatment of acute attacks.
Results:
The full burden of the home nebulised therapy is not being met by the NHS. Supply and servicing arrangements for home nebuliser therapy were poorly organised. Chronic asthma symptoms did not appear to be optimally controlled on present medication, with 61% reporting sleep disturbance in the previous three months. About 20% of parents admitted that they would give nebulised bronchodilator therapy more frequently than the recommended 3 to 4 hourly.
Conclusion:
Re-organisation of resources and arrangements could improve the service and bring it in line with recognised standards of care.